Page 122 - 《中国药房》2023年6期
P. 122

ICU常用静脉药物配伍稳定性的文献分析                                             Δ



                                                        1, 2
                                     2
                                              1, 2
                                                                  2 #
                             2
          何雪茹     1, 2* ,范理菊 ,李 宵 ,王 智 ,周 鑫 ,董占军 (1.河北医科大学研究生院,石家庄 050011;
          2.河北省人民医院药学部,石家庄 050057)
          中图分类号  R969.3      文献标志码  A      文章编号  1001-0408(2023)06-0752-06
          DOI  10.6039/j.issn.1001-0408.2023.06.21

          摘   要  目的  分析重症监护室(ICU)常用静脉药物的配伍稳定性,为临床用药安全提供参考。方法  于2022年4月1-30日调研
          并确认河北省人民医院ICU常用静脉药物,然后以此为检索词,在PubMed、中国知网、万方数据等数据库中查询相关配伍稳定性
          研究文献。借助Micromedex数据库进行手动筛选,随后对纳入文献的配伍稳定性结果进行描述性分析。结果  收集到该院ICU
          常用静脉药物32种,混合输注组合39种。共纳入40项研究,仅有2项研究符合所有的质量要求;18项研究对其方法进行了验证,
          保证了可重复性;33项研究评估了物理稳定性,包括沉淀形成、pH变化;32项研究评估了化学稳定性,主要为含量/浓度变化。共
          得到666种可能的两两配伍组合,其中254种组合有配伍稳定性结果,包括176种稳定、68种不稳定、10种相互矛盾;412种组合没
          有配伍稳定性结果。在该院ICU的两两药物组合中,42种组合稳定、14种组合不稳定、2种组合相互矛盾。结论  pH、溶媒、辅料、
          配制浓度等是影响配伍稳定性的因素;该院ICU常用静脉药物存在配伍不稳定的药物组合,且稳定性研究方法有所局限,配伍稳
          定性数据尚无法满足临床的实际需求。
          关键词  重症监护室;静脉药物;混合输注;配伍稳定性;文献分析

          Literature analysis of compatible stability of commonly used intravenous drugs in ICU
                   1, 2
                                                                 1, 2
                               2
                                        2
                                                    1, 2
          HE Xueru ,FAN Liju ,LI Xiao ,WANG Zhi ,ZHOU Xin ,DONG Zhanjun(1.  Graduate  School  of  Hebei
                                                                                  2
          Medical  University,  Shijiazhuang  050011,  China;2.  Dept.  of  Pharmacy,  Hebei  General  Hospital,  Shijiazhuang
          050057, China)
          ABSTRACT    OBJECTIVE  To  analyze  the  compatible  stability  of  commonly  used  intravenous  drugs  in  the  intensive  care  units
         (ICU), and to provide a reference for improving medication safety in clinic. METHODS The commonly used intravenous drugs in
          the  ICU  of  Hebei  General  Hospital  were  investigated  and  confirmed  in  April  1-30,  2022,  and  used  as  keywords  to  retrieve  the
          relevant  literature  about  compatible  stability  from  PubMed,  CNKI, Wanfang  Data  and  other  databases,  and  manually  filtered  with
          Micromedex database at the same time. Then, the compatible stability results of the included literature were analyzed descriptively.
          RESULTS  Totally  32  commonly  used  intravenous  drugs  and  39  mixed  infusion  combinations  were  collected  from  ICU  of  this
          hospital. A total of 40 studies were included, only 2 studies followed all quality requirements; 18 studies validated their methods to
          guarantee  correct  reproducibility;  33  studies  evaluated  physical  stability,  including  precipitate  formation  and  pH  changes;  32
          studies evaluated chemical compatibility, mainly content/concentration changes. A total of 666 possible two-drug combinations were
          obtained  from  the  included  literature,  of  which  254  combinations  of  stability  data  were  available,  including  176  were  stable,  68
          were unstable, and 10 were contradictory. Totally 412 combinations had no stability results. Among two-drug combinations in ICU
          of  this  hospital,  42  combinations  were  stable,  14  combinations  were  unstable,  and  2  combinations  were  contradictory.
          CONCLUSIONS  The pH, solvent, excipients and preparation concentration are the factors that affect the stability. There are drug
          combinations  with  unstable  compatibility  of  commonly  used  intravenous  drugs  in  ICU  of  this  hospital. The  stability  study  methods
          are limited, and the stability data cannot meet the actual clinical needs.
          KEYWORDS     intensive care unit; intravenous drugs; mixed infusion; compatible stability; literature analysis


              重症监护室(intensive care units,ICU)患者由于病            际中,同时输注的药物数量往往会超过外周和中心静脉
          情危重,通常需要同时使用多种静脉药物。理想情况                             通路数量    [1―3] ,这意味着不同药物必须通过同一条静脉
          下,每种静脉药物都应有独立的静脉通路,但在临床实                            通路给药,增加了药物不相容的发生风险。
                                                                  多通道微量泵可通过三通阀或Y型连接器将2种或
              Δ 基金项目 河北省医学科学研究课题(No.20210037)
                                                              2 种以上药物混合后输入患者血液,虽解决了多种药物
             *第一作者 硕士研究生。研究方向:临床药学。E-mail:hxr9115@
          163.com                                             同时输注静脉通路有限的问题,但可能会影响静脉药物
              # 通信作者 主任药师,硕士生导师,硕士。研究方向:临床药学。                 的配伍稳定性。由于酸碱、氧化还原、光解等特性的差
          E-mail:13313213656@126.com                          异,不同的静脉药物在混合过程中可能会发生物理或化


          · 752 ·    China Pharmacy  2023 Vol. 34  No. 6                               中国药房  2023年第34卷第6期
   117   118   119   120   121   122   123   124   125   126   127